Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept

Arthritis Rheum. 2002 Mar;46(3):843-4. doi: 10.1002/art.10096.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Rheumatoid Nodule / chemically induced*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept